Staff Time and Motion Assessment for Administration of Erythropoiesis-Stimulating Agents: A Two-Phase Pilot Study in Clinical Oncology Practices

BACKGROUND: Erythropoiesis-stimulating agents (ESAs) are used for the management of anaemia in patients with non-myeloid malignancies where anaemia is due to the effect of concomitant myelosuppressive chemotherapy. Assessing the impact of different ESA dosing regimens on office staff time and projec...

Descripción completa

Detalles Bibliográficos
Autores principales: Reitan, John F., van Breda, Arletta, Corey-Lisle, Patricia K., Shreay, Sanatan, Cong, Ze, Legg, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing AG 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634984/
https://www.ncbi.nlm.nih.gov/pubmed/23553358
http://dx.doi.org/10.1007/s40261-013-0078-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634984/
https://www.ncbi.nlm.nih.gov/pubmed/23553358
http://dx.doi.org/10.1007/s40261-013-0078-9

Ejemplares similares